标题
Considerations for Phage Therapy Against Mycobacterium abscessus
作者
关键词
-
出版物
Frontiers in Microbiology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-01-18
DOI
10.3389/fmicb.2020.609017
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fitness trade-offs resulting from bacteriophage resistance potentiate synergistic antibacterial strategies
- (2020) Mihnea R. Mangalea et al. INFECTION AND IMMUNITY
- Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus
- (2020) Matt D. Johansen et al. NATURE REVIEWS MICROBIOLOGY
- A mouse model of pulmonary Mycobacteroides abscessus infection
- (2020) Emily C. Maggioncalda et al. Scientific Reports
- Extreme Drug Tolerance of Mycobacterium abscessus “Persisters”
- (2020) Yee-Kuen Yam et al. Frontiers in Microbiology
- State-of-the-art treatment strategies for nontuberculous mycobacteria infections
- (2020) Maria-Carmen Muñoz-Egea et al. EXPERT OPINION ON PHARMACOTHERAPY
- Animal Models to Translate Phage Therapy to Human Medicine
- (2020) Alessia Brix et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Characterization and genome analysis of B1 sub-cluster mycobacteriophage PDRPxv
- (2020) Avni Sinha et al. VIRUS RESEARCH
- Mycobacterium abscessus infection leads to enhanced production of type 1 interferon and NLRP3 inflammasome activation in murine macrophages via mitochondrial oxidative stress
- (2020) Bo-Ram Kim et al. PLoS Pathogens
- Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline
- (2020) Charles L Daley et al. CLINICAL INFECTIOUS DISEASES
- Alternative and Experimental Therapies of Mycobacterium abscessus Infections
- (2020) Michal Meir et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Characterization of integrated prophages within diverse species of clinical nontuberculous mycobacteria
- (2020) Cody Glickman et al. Virology Journal
- Actinobacteriophages: Genomics, Dynamics, and Applications
- (2020) Graham F. Hatfull Annual Review of Virology
- Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States
- (2020) Saima Aslam et al. Open Forum Infectious Diseases
- Phage Therapy in the Postantibiotic Era
- (2019) Fernando L. Gordillo Altamirano et al. CLINICAL MICROBIOLOGY REVIEWS
- Mycobacteriophage ZoeJ: A broad host-range close relative of mycobacteriophage TM4
- (2019) Rebekah Dedrick et al. TUBERCULOSIS
- Phage therapy: Current status and perspectives
- (2019) Andrzej Górski et al. MEDICINAL RESEARCH REVIEWS
- Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
- (2019) Rebekah M. Dedrick et al. NATURE MEDICINE
- Current State of Compassionate Phage Therapy
- (2019) McCallin et al. Viruses-Basel
- Antimicrobial activity of Mycobacteriophage D29 Lysin B during Mycobacterium ulcerans infection
- (2019) Alexandra G. Fraga et al. PLoS Neglected Tropical Diseases
- Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review
- (2019) Taher Azimi et al. Infection and Drug Resistance
- Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus
- (2018) Tamta Tkhilaishvili et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Nontuberculous Mycobacteria in Cystic Fibrosis
- (2018) Patrick Flume et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinical Indications and Compassionate Use of Phage Therapy: Personal Experience and Literature Review with a Focus on Osteoarticular Infections
- (2018) Olivier Patey et al. Viruses-Basel
- Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles
- (2018) Lucy L. Furfaro et al. Frontiers in Cellular and Infection Microbiology
- Anti-Tuberculosis Bacteriophage D29 Delivery with a Vibrating Mesh Nebulizer, Jet Nebulizer, and Soft Mist Inhaler
- (2017) Nicholas B. Carrigy et al. PHARMACEUTICAL RESEARCH
- Prophage-mediated defence against viral attack and viral counter-defence
- (2017) Rebekah M. Dedrick et al. Nature Microbiology
- Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov.
- (2016) Enrico Tortoli et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications
- (2016) Katherine H. Luepke et al. PHARMACOTHERAPY
- Mycobacteriophage SWU1 gp39 can potentiate multiple antibiotics against Mycobacterium via altering the cell wall permeability
- (2016) Qiming Li et al. Scientific Reports
- Susceptibility of Mycobacterium abscessus to Antimycobacterial Drugs in Preclinical Models
- (2015) Andrés Obregón-Henao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Liposome-Encapsulated Bacteriophages for Enhanced Oral Phage Therapy against Salmonella spp.
- (2015) Joan Colom et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- A first step toward liposome-mediated intracellular bacteriophage therapy
- (2015) Anita Nieth et al. Expert Opinion on Drug Delivery
- Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection
- (2015) Nathan B. Pincus et al. PLoS One
- Mycobacteriophage-drived diversification of Mycobacterium abscessus
- (2014) Mohamed Sassi et al. Biology Direct
- Phage approved in food, why not as a therapeutic?
- (2014) Wessam A Sarhan et al. Expert Review of Anti-Infective Therapy
- Observation of inflammatory responses in mice orally fed with bacteriophage T7
- (2014) K. Park et al. JOURNAL OF APPLIED MICROBIOLOGY
- Phage therapy gets revitalized
- (2014) Sara Reardon NATURE
- The First Structure of a Mycobacteriophage, the Mycobacterium abscessus subsp. bolletii Phage Araucaria
- (2013) M. Sassi et al. JOURNAL OF VIROLOGY
- Bacteriophage adhering to mucus provide a non-host-derived immunity
- (2013) J. J. Barr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Abnormal Trafficking and Degradation of TLR4 Underlie the Elevated Inflammatory Response in Cystic Fibrosis
- (2011) E. M. Bruscia et al. JOURNAL OF IMMUNOLOGY
- Ongoing Phenotypic and Genomic Changes in Experimental Coevolution of RNA Bacteriophage Qβ and Escherichia coli
- (2011) Akiko Kashiwagi et al. PLoS Genetics
- Bacteriophage resistance mechanisms
- (2010) Simon J. Labrie et al. NATURE REVIEWS MICROBIOLOGY
- A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
- (2009) K. A. Nash et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started